Evidencia científica y recomendaciones sobre el tratamiento de la pediculosis

  1. Rubén Llada Suárez 1
  2. Lucía Del Fresno Marqués 1
  3. Susana Vidal Fernández 1
  4. Noelia Vázquez González 1
  1. 1 HUCA. Oviedo. España
Revista:
RqR Enfermería Comunitaria

ISSN: 2254-8270

Ano de publicación: 2018

Volume: 6

Número: 3

Páxinas: 25-41

Tipo: Artigo

DIALNET GOOGLE SCHOLAR lock_openDialnet editor

Outras publicacións en: RqR Enfermería Comunitaria

Resumo

Objective The aim of this paper is to critically discuss a systematic literature search on clinical efficacy of topical and mechanical treatments for pediculus humanus capitis (human head lice). The mode of transmission of head lice, the role of fómite transmission, prevention of infestation, diagnosis, treatment options, pharmacokinetics, resistance and safety concerns were also reviewed. Methods Spanish and English language articles indexed in MEDLINE, CINAHL, EMBASE, and the British Nursing Index (BNI) were identified, using the search terms, children, pediculicide, bug busting, head lice, pediculosis capitis, eradicate, eliminate, and infestation. Available Spanish and English language articles were selected and reviewed. Discussion Pediculosis is a common infestation particularly in school children, and causes concern in the affected family and alarm at school. Specialist community public health nurses (SCPHNs) frequently prescribe or advise parents on the use of over the counter (OTC) pediculicides. The Medimecum formulary for health practitioners 2017 apart from listing three classes of pediculicides and two shampoos, outlines the option of using wet combing as an alternative. Parents are rather reluctant to use chemicals in children and head lice clinics are becoming increasingly popular. Conclusions In view of its proven efficacy, clinical evidence, and safety, mechanical methods to remove head lice are considered an

Referencias bibliográficas

  • Amr ZS, Nusier MN. Pediculosis capitis in northern Jordan. Int J Dermatol. 2000; 39: 919-
  • Angel TA, Nigro J, Levy ML. Infestations in the pediatric patient. Pediatr Clin North Am. 2000; 47: 921-35.
  • Avis du CSHP de France. 27 juin 2003, relatif à la conduite à tenir devant un sujet atteint de pédiculose du cuir chevelu. Ann Dermatol Venereol. 2004; 131: 1122-4.
  • Bartels CL, Peterson KE, Taylor KL. Head lice resistance: Itching that just won’t stop. Ann Pharmacother. 2001; 35: 109-12.
  • Brandenburg K, Deinard AS, Di Napoli J, Englender SJ, Orthoefer J, Wagner D. 1% permethrin cream rinse vs 1% lindane shampoo in treating pediculosis capitis. Am J Dis Child. 1986; 140: 894-6.
  • Burgess I, Lee P, Matlock G. Randomised, controlled, assessor blind trial comparing 4% dimeticone lotion with 0,5% malathion liquid for head louse infestation. PLoS One. 2007; 2(11): e1127.
  • Burgess I. Current treatments for pediculosis capitis. Curr Opin Infect Dis. 2009; 22(2): 131-6. Burgess I. The life of a head louse. Nurs Times. 2002; 98: 54.9.
  • Burgess IF, Brown CM, Lee PN. Treatment of head louse infestation with 4% dimeticone lotion: randomised controlled equivalence trial. BMJ. 2005; 330: 1423.
  • Burkhart CG. Relationship of treatment-resistant head lice to the safety and efficacy of pediculicides. Mayo Clin Proc. 2004; 79: 661-6.
  • Canadian Paediatric Society (CPS). Head lice infestations: A clinical update. Paediatr Child Health. 2008; 13(8): 692-704.
  • Canyon DV, Speare R, Muller R. Spatial and kinetic factors for the transfer of head lice (Pediculus capitis) between hairs. J Invest Dermatol. 2002; 119: 629-31.
  • Carson DS, Tribble PW, Weart CW. Pyrethrins combined with piperonyl butoxide (RID) vs 1% permethrin (NIX) in the treatment of head lice. Am J Dis Child.1988; 142: 768-9.
  • Centers for Disease Control and Prevention [Internet]. Atlanta: CDC online document. Head lice. [consultado 28 Ene 2018].
  • Chosidow O. Scabies and pediculosis. Lancet. 2000; 355: 819-26.
  • Chunge RN. A study of head lice among primary schoolchildren in Kenya. Trans R Soc Trop Med Hyg. 1986; 80: 42-6.
  • Counahan M, Andrews R, Buttner P, Byrnes G, Speare R. Headlice prevalence in primary schools in Victoria, Australia. J Paediatr Child Health. 2004; 40: 616-9.
  • Cueto, GM, Zerba, EN, Picollo, MI. Permethrin-resistant head lice (Anoplura: Pediculidae) in Argentina are susceptible to
  • Devore CD, Schutze GE. Council on School Health and Committee on Infectious Diseases, American Academy of Pediatrics. Head lice. Pediatrics. 2015; 135(5): e1355-65.
  • Dodd CS. Interventions for treating head lice. Cochrane Database Sys Rev. 2001; 3: CD001165.
  • Downs AM, Harvey I, Kennedy CT. The epidemiology of head lice and scabies in the UK. Epidemiol Infect. 1999; 122: 471-7.
  • Downs AM, Stafford KA, Harvey I, Coles GC. Evidence for double resistance to permethrin and malathion in head lice. Br J Dermatol. 1999; 141: 508-11.
  • Downs AM, Stafford KA, Hunt LP, Ravenscroft JC, Coles GC. Widespread insecticide resistance in head lice to the over the counter pediculocides in England, and the emergence of carbaryl resistance. Br J Dermatol. 2002; 146: 88-93.
  • Durand R, Millard B, Bouges-Michel C, Bruel C, Bouvresse S, Izri A. Detection of pyrethroid resistance gene in head lice in school children from Bobigny, France. J Med Entomol. 2007; 44: 796-8.
  • Elewski BE. Clinical diagnosis of common scalp disorders. J Investig Dermatol Symp Proc. 2005; 10: 190-3.
  • Elston DM. Controversies concerning the treatment of lice and scabies. J Am Acad Dermatol. 2002; 46: 794-6.
  • Falagas ME, Matthaiou DK, Rafailidis PI, Panos G. Worldwide Prevalence of Head Lice. Emerg Infect Dis. 2008; 14: 1493-5.
  • Frankowski BL, Bocchini JA. Head lice. Pediatrics. 2010;126(2):392-403.
  • Guenther L, Maguiness S. Pediculosis and pthiriasis (lice infestation). eMedicine online document [consultado 28 Ene 2018].
  • Heukelbach J, Pilger D, Oliveira FA, Khakban A, Ariza L, Feldmeier H. A highly efficacious pediculicide based on dimeticone: randomized observer blinded comparative trial. BMC Infect Dis. 2008; 8: 115.
  • Heukelbach J, Wilcke T, Winter B, Feldmeier H. Epidemiology and morbidity of scabies and pediculosis capitis in resource-poor communities in Brazil. Br J Dermatol. 2005; 153: 150-6
  • Hill N, Moor G, Cameron M, Butlin A, Preston S, Williamson M et al (2005). Single blind, randomised, comparative study of the Bug Buster kit and over the counter pediculicide treatments against head lice in the United Kingdom. British Medical Journal. 2005 aug; 7513(331): 384-7.
  • INFAC. Actualización del tratamiento de la pediculosis.
  • Irurzun SA. Vuelve “el cole” y… vuelven los piojos. Acofar: revista de la distribución farmacéutica cooperativista. 2013(526):42-46.
  • Izri MA, Brière C. Premiers cas de résistance de Pediculus capitis Linné 1758 au malathion en France. Presse Med 1995; 24: 1444.
  • Jacobson CC, Abel EA. Parasitic Infestations. J Am Dermatol. 2007; 56: 1026-43.
  • Janniger CK, Kuflik AS. Pediculosis capitis. Cutis. 1993; 51: 407-8.
  • Kristensen M, Knorr M, Rasmussen AM, Jespersen JB. Survey of permethrin and malathion resistance in human head lice populations from Denmark. J Med Entomol. 2006; 43:533-8.
  • Lebwohl, M, Clark, L, Levitt, J. Therapy for head lice based on life cycle, resistance, and safety considerations. Pediatrics. 2007; 119: 965-74.
  • Leung AK, Fong JH, Pinto-Rojas A. Pediculosis capitis. J Pediatr Health Care. 2005; 19: 369-73.
  • Leung AK, Fong JH, Pinto-Rojas A. Pediculosis capitis. J Pediatr Health Care. 2005; 19: 369-73.
  • Management of head lice in primary care. MeReC Bulletin. 2008;18(4).
  • Meinking TL, Serrano L, Hard B, Entzel P, Lemard G, Rivera E, et al. Comparative in vitro pediculicidal efficacy of treatment sin a resistant head lice population in the United States. Arch Dermatol. 2002; 138: 220-4.
  • Meinking, TL, Vicaria, M, Eyerdam, DH, Villar, ME, Reyna, S, Suarez, G. A randomized, investigator-blinded, time-ranging study of the comparative efficacy of 0.5% malathion gel versus Ovide lotion (0.5% malathion) or Nix Crème Rinse (1% permethrin) used as labeled for the treatment of head lice. Pediatr Dermatol. 2007; 24: 405-11.
  • Mumcuoglu KY, Meinking TA, Burkhart CN, Burkhart CG. Head louse infestations: the “no nit” policy and its consequences. Int J Dermatol. 2006; 45: 891-6.
  • Mumcuoglu KY, Miller J, Gofin R, et al. Head lice in Israeli children: parents’ answers to an epidemiological questionnaire. Public Health Rev. 1990; 18: 335-44.
  • Mumcuoglu KY. Effective treatment of head louse with pediculicides. J Drugs Dermatol. 2006; 5: 451-2.
  • Nutanson CJ, Steen RA, Schwartz RA, Janniger CK. Pediculus humanus capitis: An update. Acta Dermatovenerol Alp Pannonica Adriat. 2008; 17: 147-59.
  • Roberts RJ, Casey D, Morgan DA, Petrovic M. Comparison of wet combing with malathion for treatment of head lice in the UK: a pragmatic randomised controlled trial. Lancet. 2000; 356.
  • Sackett DL, Richardson WS, Rosenberg W, and Haynes RB. Evidence Based Medicine: how to practice and teach EBM. London. Churchill Livingstone, 1997.
  • Sciscione P, Krause-Parello CA. No-nit policies in schools: time for change. J Sch Nurs. 2007; 23: 13-20.
  • Soler B, Castellares C, Viver S, Díaz L, Gómez R, Ruíz E. Ensayo clínico aleatorizado para evaluar la eficacia y seguridad en la erradicación del Pediculus humanus capitis de un nuevo pediculicida elaborado con aceite de oliva saponificado. SEMERGEN. Medicina de Familia. 2017; 43(2): 91-9.
  • Speare R, Buettner PG. Hard data needed on head lice transmission. Int J Dermatol. 2000; 39: 877-8.
  • Speare R, Cahill C, Thomas G. Head lice on pillows, and strategies to make a small risk even less. Int J Dermatol. 2003; 42: 626-9.
  • spinosad. J Med Entomol. 2005; 43: 634–5.
  • Steen CJ, Carbonaro PA, Schwartz RA. Arthropods in dermatology. J Am Acad Dermatol. 2004; 50: 819-42.
  • Stough, D, Shellabarger, S, Quiring, J, Gabrielsen, AA. Efficacy and safety of spinosad and permethrin crème rinses for Pediculosis capitis (head lice). Pediatrics. 2009; 124: e389– 95.
  • Taplin D, Meinking TL, Castillero PM, Sanchez R. Permethrin 1% creme rinse for the treatment of Pediculus humanus var capitis infestation. Pediatr Dermatol. 1986; 3: 344-8.
  • Vander Stichele RH, Dezeure EM, Bogaert MG. Systematic review of clinical efficacy of topical treatments for head lice. BMJ. 1995; 311: 604-8.
  • Vassena CV, Mougabure CG, Gonzalez AP, Alzogaray RA, Zerba EN, Picollo MI. Prevalence and levels of permethrin resistance in Pediculus humanus capitis De Geer (Anoplura: Pediculidae) from Buenos Aires. Argentina J Med Entomol. 2003; 40: 447-50.
  • Villa LF, coord. Medimecum. Guía de terapia farmacológica. 22ª ed. Barcelona: Eviscience Publications; 2017.
  • Wolf R, Davidivici B. Treatment of scabies and pediculosis. Facts and controversies. Clinics in Dermatology 2010: 28, 511-8.
  • Yoon KS, Gao JR, Lee SH, Clark JM, Brown L, Taplin D. Permethrin resistant human head lice, Pediculus capitis, and their treatment. Arch Dermatol. 2003; 139: 994-1000.
Fonte de datos: Dialnet